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INTRODUCTION
Light has recently been reported to be a useful treatment in affective illness (1,2,
3, 4, 5, 6). What type of patients respond to thi s type of treatment ? What is the
theoretical mechanism of action of light therapy and what are the impl icat ions of th is
research for the existing theories of affective illness? Th is review will seek answers to
these questions by summarizing the recentl y reported studies of the effects of light on
depression , by reviewing the pertinent contributions from neuroanatomy, endocrinol-
ogy and circ adian rhythm physiology, and, finally, by sugges ting some points of
integration of these recent findings with existing theories of depression.
HISTORICAL ASPECTS OF SEASONAL MOOD CHANGES
Hippocrates wrote : "If any violent change has occurred in the air according to
seasons , the brain becomes different from what it was" (7). Hellpach, in 1911, was the
first in modern medical literature to notice the existence of seaso nal mood changes in
manic-depressive patients (I). Kraeplin, in 1921, agreed with Hellpach and further
described such patients as follows: "Repeatedly I saw moodiness set in in the autumn
and pass over in the spring, when the sap shoots in the trees to excitemen t,
corresponding in a certain sense to the chang es which come over even health y
individuals at the changes of the seasons" (8). Several recent epidemiological studies
have shown seasonal variation in the preponderance of affective illness, with peak rat es
for depression (both unipolar and bipolar) in the spring and fall of the year, and peak
rates for suicide in the summer months (1,9, 10, 11).
The length of day , or photoperiod, is one variable that may be linked with seasonal
variations of depression in susceptible individuals.
USING LIGHT TO TREAT DEPRESSION
The first case of using artificial light in the treatment of affective illness was
reported by Lewy, et al (2). The subject was a sixty-three-yea r-old male, diagnosed by
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Research Diagnostic Criteria (13) as having a bipolar-II major depressive disord er,
who had not responded to a variety of antidepressant dru gs due to intolerable side
effects. The patient kept a diar y for fourteen years docum enting a history of:
hypomanias beginning in Januar y or Februa ry of each year, eac h lasting an average of
22 weeks; and of depressions beginning in Jul y of each year, eac h lasting at least 29
weeks. Dur ing December 1980, sixteen weeks into a depressive episode, he was exposed
to fluorescent light (Vitalite) of 2000 lux intensity between his time of awakening at
6:00 until 9:00 A.M . and again between 4:00 and 7:00 P.M., thus extending his
photoperiod to thirteen hours (i.e., a spring photoperiod compared to a ten-hour
December photoperiod with dawn at 7:00 A.M. and dusk at 5:00 P.M.). After four
day s of this regimen, the patient appeared markedly improved with Visual Analog
Mood Scale self-ratings increasing from (+ - S. D.) 20( + - 2) to 39( + - I) (50 = eu-
thymia) . Nurses' ratings of depression declined significa ntly and 24-hour activi ty
counts increased from a mean of 4748 to 7003 .
Rosenthal and colleagues reported a case of a twent y-nine-year-old woman who
regularly suffered depressions every winter and hypomanias every spring since earl y
adolescence (1). These cycles were strongly effected by the relative latitude of her
residence, i.e., the further north she lived, the earlier her fall depressions began with
more severe and long lasting symptoms. Earl y morning light thera py was reportedly
used successfully beginning in August when her depr essive cycle began, and this
therapy reportedly continued to be beneficial during the fall and winter for four years
of follow-up .
A more systematic study was subsequently done by Rosenthal et al (I). Eleven
subjects were screened from 2000 applicants who responded to a news article
describing the above patient. For inclusion in the study the patients had to have a
history of major affective disorder according to RDC criteria ( 13), with onset in the
fall or winter for at least two consecutive years and subsequent remissions in the
following spring or summer. Patients were then followed with regular clinic visits until
the y began to feel depressed (assessed by self-report , clinica l interview, and Hamilton
and Beck Depression Rating Scales). When pati ent s becam e modera tely depressed for
two weeks, they were offered experimental light treatment. Two kinds of light were
used: a) bright full spectrum fluorescent light, approxima tely 2500 lux at 90 cm; and
b) dim yellow fluorescent light of 100 lux intensity at 90 em (used as a control) .
Patients were requested to sit in front of the light s doing some activity other than
sleeping for three hours before dawn and three hour s after dark. A crossover study was
performed such that if clinical improvement was noted after two weeks of eithe r bright
or dim light therapy both lights were withdrawn for one week before the alternate light
therapy was begun. Improvement was defined by psychiatric intervi ew and a Hamilton
Score of less than fifteen. If no improvement was noted after two weeks the second
regimen was begun without delay .
Results showed that those patients treated with bright white light showed
significant antidepressant effects with a mean Hamilton Rating Scale (HRS) pret reat-
ment score of 17.7+ - 3.7 and a postreatment score of 6.7+ - 5.1 (p < .001) . Those
patients exposed to dim light (control) showed a nonsignificant change in mean HRS
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score from a pretreatment baseline of 15.41 + - 4.6 to 13+ -7.1. There was a
sta tistica l difference in the change in HRS score induced by bright white light versus
dim yellow light (p < .0 I) when a paired t test was performed. Seven patients requested
to be restarted on the bright light regimen at the end of the crossover study, and first
and second responses to light treatment were similar in all cases. Mood improvement
with bright light was noted within three to seven days of therapy, and relapse occurre d
to a significant degree (t = 3.29; P < .0 1; two tailed paired t test) after withdrawal of
the light within three to four days on the average.
CHARACTERISTICS OF RESPONDERS TO LIGHT THERAPY
Seventy-six percent of Rosenthal's patients were diagnosed as bipolar-II and
seventeen percent as bipolar-I , though man ia was not a selection criterion. One-th ird of
the pat ients had never received psychiatric treatment and only three had been
previously hospitalized suggesting that Seasonal Affective Disorder (SAD) may be a
mild vari ant of manic -depression as Kraeplin had originally sta ted (7). Rosenthal
further points out that SAD seems to be a bipolar varia nt of so-called "atypica l"
depression with frequent symptoms of hypersomn ia, hyperphagia, carbohydrate
craving, and weight gai n.
The outs ta nding clin ical feature of SAD , noted by Rosenthal and colleagues, was
a sensitivity to changes in season or lat itud e that cor responded to the approxima te
annua l occurrence of affective episodes. Of Rosentha l's patients, 83% described their
moods as worsening with nort hward trav el and symptom amelioration after traveling
south (wit hin the northern hemisphere). The prevalence of seasonal exacerbations in
manic-depressive pat ient s was noted by Kraeplin to be four or five percent (7).
Rosenthal suggests that the disorder may be more frequent than the literature shows,
pointing out that a rhythm with a period of one year is difficult for both pat ient and
doctor to perceive. Thi s, together with the findings that these pat ients have relati vely
milder hyperphagic, hypersornnic, and anergic symptoms, may contribute to these
patient s being misdiagnosed or never treat ed.
POTENTIAL RESEARCH PROBLEMS USING LIGHT THERAPY
In the ir discussion, Rosenthal and colleagues point out possible problems with the
interpretation of their results. These are: a) that the news article may have screened for
suggesta ble subjects who expected a similar result to that described; b) that the dim
(control) light could not be " blind" to the subjects; c) that sleep deprivation in the
second half of the night is known to have antidepressant effects (21) and since subjects
were sometimes awakened in the morning for light therapy, this effect must be
controlled for; and, finally, d) that a sea rch should be made for psychosocial variables,
such as anniversa ry reactions and holiday depression.
In a recently reported study (5), Rosenthal and colleag ues further studied the
effects of light treatment in SAD, using a similarly designed study with some notable
exceptions: a) seven outpatients were studied as well as six additional inpatients, and b)
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sleep was monitored polysomnographically during the study. Pertinent highlights will
be presented here. (The reader is referred to the original article for further details.)
Using more rigorous statistical analysis than in their earlier study, Rosenthal and
colleagues closely replicated their earlier findings of the antidepressant action of bright
white light in SAD compared to dim light controls. No significant differences were
noted comparing the response of outpatients versus inpatient s, nor were there any
significant differences in the mean sleep time in subjects getting bright versus dim light
treatment during either baseline, treatment, or withdrawal cond itions. Rosenthal
admits that some phase advance of the sleep cycle (referred to in depth later in this
review) occurred when subjects were awakened at 5:00 A.M. for light therapy; but
argues that sleep deprivation or phase advancement cannot be sufficient to explain the
noted antidepressant response since the sleep effects were present in both bright and
dim light treatment settings, but only those subjects exposed to bright light treatment
showed a significant antidepressant response. On the issue of patient expectations in
the "nonblind" crossover aspect of the study, Rosenthal argues agai nst a placebo
explanation of the study findings by emphasizing the similarity of first and second
responses to bright light, the latency of the response and relapse (a few da ys), and the
successful use of maintenance light therapy in four subjects throughout the winter (5).
Rosenthal reports that although his group has successfully maintained an antidepres-
sant response using bright white light therapy in ten patients diagno sed with SA D,
regular exposure is critical for maintenance with relapse occurring in a few days if light
therapy is omitted.
Rosenthal concludes that a) Seasonal Affective Disorder is a subgroup of
affective illness wherein susceptible patients show apparent react ivity to environmental
factors , b) that preliminary evidence suggests that artificially man ipulat ing environ-
mental light may be clinically useful in treating these pati ent s, and c) that fur ther work
is required to validate SAD as a distinct clin ical syndrome.
A THEORETICAL MECHANISM OF ACTION OF LIGHT THERAPY
Understanding how light could effect depression involves relat ed research in
neuroanatomy, endocrinology, and in the physiology of biological rhythms as they
relate to affective illness .
Many animal species show seasonal or circannual rhythms that are known to
control such phenomena as migration, breeding patterns, and hibernation ( 12). The
control of these rhythms have been shown to be endogenous in origin, i.e., that they
continue to manifest themselves in the absence of environmental stimuli , al though
environmental stimuli are known to influence or regulate the timing of these rhythms.
Of these environmental stimuli, the photoperiod seems to be the most influential (2).
THE NEUROANATOMY OF BIOLOGICAL RHYTHMS
Circadian rhythms (meaning: of about 24 hours) have been studied in many
animal species, including man, and are known to occur in such physiological par ame-
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ters as cortisol secretion, fluctuations in body temperature, REM sleep propensity, and
melatonin secretion (12, 14, 15) . Ablative experiments have shown these rhythms to be
controlled by an endogenous brain pacemaker located in the suprac hiasmatic nucleus
(SCN) of the hypothalamous (15 , 16, 17). This brain center rece ives neural input from
the retina via several neural tracts, of which the retinohypothalamic tract has been
shown to mediate the effects of light on biological rhythms (12 , 17). Further neural
pathways have been shown connecting the SCN to the thorac ic spina l cord nucleii and,
subsequently, the pineal gland via noradrenergic neurons tr aversing the superior
cervical ganglion (17). Hence, the effects of light impinging on the ret ina are re layed
via neural pathways to the CNS pacemaker for biological rh ythms and subsequently to
the pineal gland.
Embryologically the pinealacytes are known to have evolved from photoreceptor
cells in lower animals smiliar to those found in the lateral eyes of certa in animals ( 16,
17). In higher animals the pineal is no longer directly sensitive to ligh t; its effects
require the above neural pathways to relay information about environm ental light
(17) . The blinding of experimental animals, as well as ablat ion of the SCN , pineal
gland, or any of the neural connections between them, have been shown to prevent the
regulatory effects of light on certain biological rhythms (12 ).
THE PINEAL GLAND AND MELATONIN IN BIOLOGICAL RHYTHMS
The function of the pineal gland is a subject of continuing intensive study,
particularly in relation to biological rhythms. The pineal gland is known to secrete
indolamine hormones and certain peptides (14, 15, 16, 17, 18). Melat onin, an
indoleamine hormone synthesized from sera tonin, is secreted by the pineal glan d in a
diurnal rhythm. Peak below levels occur during the nighttime sleep of hum ans and
during the nighttime active period of nocturnal animals (in the absence of environ-
mental light) (17) . Light impinging upon the retina is known to immediat ely suppress
the secretion of melatonin (16 , 17, 18) . Interestingly, humans seem to require ligh t of
considerably higher intensity than animals to suppress melat onin, perh aps due to
man's adaptation to an artificially lit environment (20) . The function of melat onin is a
subject of great speculation and few known fact s. Whether melatonin is an endocrine
messenger linking the light/dark cycle with biological rh ythms in hum ans remains a
question under intensive study. Some studies do, however , demonstrat e such effects in
animals .
Seasonal reproductive cycles in animals are attributed to antigonadal properties
of melatonin. At least one mechanism involves melatonin changing the sensitivity of
gonadatropin control centers to negative feedback by steroid sex hormones (12) . Thus,
seasonal changes in the length of the photoperiod modulate blood levels of melatonin,
which in turn controls seasonal reproductive cycles through its effect s on gonadatropic
function .
Comparatively less is known about the function of melatonin in man . A few small
studies have reported giving exogenous melatonin to humans to test its effects on
Parkinson's Disease and depression . Using doses up to six gr ams per day, no beneficial
effect was noted in Parkinson's Disease (21) and increased dysphoria was noted in a
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study of eight depressed patients given melatonin (22) . Th e most frequent effects noted
were sedation and somnolence (21, 22) .
In summary, light has been proven to regul at e the biological rhythm of seasonal
reproductive cycles in animals. Information about fluctu at ions in environmental light
is relayed from the eye to the circ adi an pacemaker (Se N ) and pineal gland . Thus ,
light indirectly regulates pineal melatonin secretion which in turn alters the gonado-
tropic control of reproductive cycles. Whether an analogous mechani sm affects those
biological rhythms relevant to depression remains speculative at this time.
BIOLOGICAL RHYTHMS IN DEPRESSION
The hypothesis that circadian rhythm disturbance could be involved in affective
illness originally evolved from consideration of four clinic al fea tures of depression:
early morning awakening, diurnal vari ation of symptom severity, seasonalit y, and
cyclicity of the illness (14) .
When the sleep architecture of normal subjects is sampled du ring short naps
around the clock, REM sleep also exhibits a circadian rhythm with a REM sleep peak
in the midmorning and a minimum in the late afternoon. Thus REM sleep in normal
subjects predominates in the later half of the sleep cycle.
The sleep EEGs of depressed patients show that R EM sleep occurs earlier in the
sleep period than in nondepressed controls (23) . The sleep disturbances seen in
depression with shortened REM latency, short total sleep time, and early morning
awakening can be mimicked in norm al subjects by shifting the onset of sleep from 10
P.M. to 10 A.M. Wehr and colleagues thus specul ated that the circadian rhythm peak
of REM sleep may occur abnormally early in depression, that is, phase advanced,
relative to the sleep period . Wehr states: "If this inference is relevant to the etiology of
affective illness, advancing a patient's sleep period by severa l hours should alter the
internal phase relationship between the circadian sleep-wake cycle and other circa dian
rhythms (such as temperature or the probability of REM sleep) so as to norm alize both
sleep architecture and mood" (23). This observation led Wehr and colleagues to
experimentally phase advance a depressed patient's sleep cycle by six hours, that is,
from the conventional 11:00 P.M. to 7:00 A.M. sleep period to a 5:00 P.M. to 1:00
A.M. sleep period. These investigators reported a complete remission of depressive
symptoms followed by a slight hypomanic state. Two weeks later the pat ient relapsed
and a second six-hour phase shift produced a similar remis sion. Wehr , et ai, reported
similarly successful results with three additional patients using phase advance therapy
(19) .
Thus, a particular imbalance in the temporal relationship of REM sleep to the
total sleep cycle is postulated to cause depression.
ENVIRONMENTAL LIGHT ENTRAINS BIOLOGICAL
RHYTHMS IN MAN
Several investigators have shown that if hum an subjects are kept in artificially
controlled constant light or dark environments, the circ adian rhythms controlling body
12 Je fferson Journal of Psychiatry
temperature, cortisol secretion, and REM sleep propensity continue to show endoge-
nous (or free-running) cycles which a re slightl y longer than the expected 24-hours,
e.g., 25-28 hours (12, 14,24). This suggests that human, as well as animal circadian
rhythms, are continually adjusted to maintain a 24-hour period icy by the preva iling
light/dark cycle .
DESYNCHRONIZED CIRCADIAN PACEMAKERS IN DEPRESSION
Goodwin and colleag ues postulate a more complex model consisting of two
pacemakers or oscillators; a strong one controlling body temperature, REM sleep
propensity and cortisol secretion; and a weak one controlling the sleep cycle and sleep
related neuroendocrine activity (14) .
Goodwin states that: "Light acting on circadian oscillators is the basis of seasonal
and annual biological rhythms. Phase shift experiments and rapid tran smer idian travel
can temporarily dist urb the normal phase relationships between the two circadian
oscillators and their overt rhythms. It is reasonable to assume that such a system of
oscillators may be altered by disease or by treatment interventions. Th e intrinsic period
of the oscillators could be altered or changes could occur in the coupling to the external
day/ night cycle" (14).
SUMMARIZING THE PROPOSED ANTI DEPRESSANT
ACTION OF LIGHT THERAPY
Individ uals with SAD are postulated to have some impairment in the coupling of
their biological rhythms with the day/night cycle such that the shorte r days of winter
ca use the biological rhythm for REM sleep to peak abnormally earl y in the sleep cycle,
producing depression according to the model proposed by Wehr, et al (23). If such a
mecha nism is correct, then artificially exte nding the photoperiod to one "seen" by the
biological rhythm control system as a spring day could norm alize the REM sleep
abnormality, thus relieving depression in SAD. A mechanism similar to the retina-
SeN-pineal-melatonin axis out lined in the control of mammalian seaso nal reproduc-
tive cycles may underlie the manner in which shorter photoperiods alter biological
rhythms and hence mood. Presenting the retina with light of a desired intensity and
du ration could then be potentially used to normalize the biological rhythms altered in
SAD.
INTEGRATING BIOLOGICAL RHYTHMS WITH OTHER
THEORIES OF DEPRESSION
Goodwin noted in animal studies that the number of various brain receptors
(a lpha and beta adrenergic, cholinergic, dopaminergic, opiate, and benzodiazepine
receptors) also show circadia n rhythm fluctuations and that chronically adminis tering
imipramine (a tricyclic) or chlorgyline (an MAOI inhibitor) pha se delayed the diurnal
variation in all receptors to various degrees, e.g., peak alpha adrenergic receptor
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binding occurred twelve hours later in drug treated patients than in untr eated controls
(other wave characteristics were also changed) (14 ,25). Lithium has also been shown
to slow circadian rhythms in animals (25). These studies suggest that antidepressant
drugs may alleviate depression by phase delaying the depressed pat ient's already phase
advanced circadian rhythms, restoring them to a more homeostat ic sta te.
Lingjaerde, in 1983, reviewed the biochemistry of depression (26), citing the well
known biogenic amine theories, the more recent neuroendocrine findings in depression
that underlie the use of the dexamethasone suppression test (DST) and the thyrotropin
releasing hormone (TRH) test. He also includes the question of biological rhythms,
suggesting that they not be viewed separ ately, but integrated with existing theories.
Lingjaerde states: "It is not unreasonable to assume that the function of the
hypothalamic nucleus is dependent on monoaminergic mech anisms. If so, general
hypofunction, or inherent lability in noradrenergic or seratonergic functions may well
predispose to disturbances in the regulation of circadian rhythms. Thus it is clear that
disturbed biological rhythms are to be regarded . . . as a distu rbance that is most
intimately connected with disturbances in monoaminergic and neur oendocrinological
functions" (26) .
DISCUSSION
Treating depression in properly diagnosed patients with light therapy is an
excit ing concept to potentially add to the psychiatrist's ar mamentarium. Much
research remains to be done to confirm previous work with larger numbers of subjects
in controlled studies, selecting subjects with seasonal symptoms from lar ger groups of
depressed patients, and devising reliable ways to select out those patients with
seasonally dependent psychosocial determinants of depression.
Perhaps even more significant are the implications of the theoretical mechanism
of action of light therapy in the etiology of depression. Circadi an rhyth m research in
affective illness offers, in the author's opinion , the most novel conceptualization of
affective illness since the biogenic amine hypothesis. The level of knowledge, at this
time, of even the most fundamental aspects of the etiology of depression is by no mean s
clear. Current biological research seems focused on neurotran smitt er altering drugs
and receptor physiology. Could some of thi s research explain more of the complete
picture if data were also viewed from the perspective of alte red biological rhythms?
Anna Wirz-Justice points out that biochemical determinations such as platelet
seratonin concentrations reveal new dimensions when ana lyzed with circadian (as well
as circannual) variability in mind as opposed to single point determinati ons (7). Could,
for example, the lag time in the onset of action of tricyclic antidepressants be explai ned
by the time required for these drugs to norm alize the biological rhy thm distu rbances of
depression?
Do antidepressant drugs work by acting on the aminergic neur al systems that are
known to control biological rhythms, as Lingjaerde suggests? Th e fac ts that a) the
SCN has the highest concentration of seratonergic neurons in the hypothalamous, b)
that the control of melatonin secretion is a noradrenergic syste m, and c) that the
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number of monoaminergic receptors themselves show ci rcadian rhythm period icy that
is a ltered by a nti depressant drugs (including lit hiu m in ra ts) a ll suggest some point s of
potential integra t ion between biogenic a m ines, receptor ph ysiology, and biological
rh ythms.
Future depression research will undoubtedly sho w new perspect ives in th e design
of studies th at more fully integrate th e tenets of biologi cal rhythm research with the
more prevalent re search based on theories of synaptic ph ysiology.
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